Key facts
- Notable investors include Horizon Capital (China).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Qidix
- ·The full record, as it builds
Funding rounds
No funding rounds for Qidix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Qidix
Manufacturer of diagnostic sample collection systems designed for clinical and home use. The company offers saliva and swab-based collection kits with features such as sample sufficiency indicators, detachable tips, and virus-preserving transport buffers, enabling healthcare providers and non-professional users to safely and accurately collect, store, and transport biological samples for further analysis.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2022
- Website
- qidix.cn/
- Ownership
- Privately Held (backing)
Qidix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Qidix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Qidix in its N-PORT filings yet. We sweep new filings monthly.